Theriva Biologics Inc (AMEX:TOVX)

$ 1.45 -0.02 (-1.36%) Market Cap: 4.04 Mil Enterprise Value: -10.63 Mil PE Ratio: 0 PB Ratio: 0.15 GF Score: 23/100

Q4 2023 Theriva Biologics Inc Earnings Call Transcript
Mar 25, 2024

$12.34 (-5.04%)

Earnings
Q3 2023 Theriva Biologics Inc Earnings Call Transcript
Nov 13, 2023

$11.01 (-6.34%)

Earnings
Q2 2023 Theriva Biologics Inc Earnings Call Transcript
Aug 08, 2023

$15.68 (-2.15%)

Earnings
Q1 2023 Theriva Biologics Inc Earnings Call Transcript
May 11, 2023

$17.22 (-3.33%)

Earnings
Q4 2022 Theriva Biologics Inc Earnings Call Transcript
Mar 30, 2023

$17 (+0.01%)

Earnings
Q3 2022 Theriva Biologics Inc Earnings Call Transcript
Nov 11, 2022

$15.42 (-3.90%)

Earnings
Theriva Biologics Inc KOL Webinar Transcript
Nov 07, 2022
Q2 2022 Synthetic Biologics Inc Earnings Call Transcript
Aug 11, 2022

$35.5

Earnings
Q1 2022 Synthetic Biologics Inc Earnings Call Transcript
May 16, 2022

$57.6 (+0.61%)

Earnings
Q4 2021 Synthetic Biologics Inc Earnings Call Transcript
Mar 16, 2022

$63.03 (+5.04%)

Earnings
Synthetic Biologics Inc Operational Update Call Transcript
Dec 14, 2021
Q3 2021 Synthetic Biologics Inc Earnings Call Transcript
Nov 03, 2021

$108.13 (-3.05%)

Earnings
Q2 2021 Synthetic Biologics Inc Earnings Call Transcript
Aug 05, 2021

$127.08 (-0.35%)

Earnings
Q1 2021 Synthetic Biologics Inc Earnings Call Transcript
May 05, 2021

$126.45 (-2.09%)

Earnings
Full Year 2020 Synthetic Biologics Inc Earnings Call Transcript
Mar 04, 2021

$145.03 (-9.99%)

Earnings
Q3 2020 Synthetic Biologics Inc Earnings Call Transcript
Nov 10, 2020

$85.5 (+3.64%)

Earnings
Q2 2020 Synthetic Biologics Inc Earnings Call Transcript
Aug 06, 2020

$148.7 (-0.45%)

Earnings
Q1 2020 Synthetic Biologics Inc Earnings Call Transcript
May 05, 2020

$86.88 (+2.21%)

Earnings
Q4 2019 Synthetic Biologics Inc Earnings Call Transcript
Feb 20, 2020

$125 (-3.74%)

Earnings
Q3 2019 Synthetic Biologics Inc Earnings Call Transcript
Nov 04, 2019

$112.5 (+6.28%)

Earnings
Q2 2019 Synthetic Biologics Inc Earnings Call Transcript
Aug 08, 2019

$117.6 (+0.09%)

Earnings
Q1 2019 Synthetic Biologics Inc Earnings Call Transcript
May 08, 2019

$150.53 (-2.89%)

Earnings
Q4 2018 Synthetic Biologics Inc Earnings Call Transcript
Feb 27, 2019

$162.5 (-2.40%)

Earnings

Theriva Biologics Inc KOL Webinar Transcript

Nov 7, 2022 / 04:00 PM GMT

Release Date Price: $18.27 (+1.12%)

Transcript 8-K10-Q

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TOVX.A - Theriva Biologics Inc
Theriva Biologics Inc KOL Webinar
Nov 07, 2022 / 04:00PM GMT

=====================
Conference Call Participants
=====================
* James Francis Molloy
Alliance Global Partners, Research Division - MD of Equity Research and Biotechnology & Specialty Pharmaceuticals Equity Research Analyst
* Arsen Osipov
* Michael A. Morse
* Michael Cozart

=====================
Presentation
--------------------------------------------------------------------------------
Michael Cozart, [1]
--------------------------------------------------------------------------------
Good morning, everyone, and thank you for joining today's KOL webinar. My name is Michael Cozart, and I'm a Managing Partner at LifeSci Consulting, a leading life sciences strategy consulting and transaction advisory firm located in New York City.

This morning, we will be discussing Theriva's novel oncolytic virus program, and in particular, the program's potential to treat pancreatic

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.